{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2553, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style chart to represent the development status of various gene therapy programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/8", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "7bbb1ef5-c9d3-47b7-af2c-e4525cf9b6a5", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents Taysha's traction, solution, and roadmap, generating interest in the company's approach.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The chart uses a staircase/waterfall visualization to show individual disease populations contributing to a total addressable market.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/9", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "7bbb1ef5-c9d3-47b7-af2c-e4525cf9b6a5", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents Taysha's traction, solution, and roadmap, generating interest in the company's approach.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "The slide uses an upward-trending arrow diagram to represent progress or acceleration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/10", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "7bbb1ef5-c9d3-47b7-af2c-e4525cf9b6a5", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents Taysha's traction, solution, and roadmap, generating interest in the company's approach.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "business_model", "function": "present_solution", "notes": "The slide uses line charts to illustrate revenue or patient growth trajectories over time (Q1-Q15).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/11", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "7bbb1ef5-c9d3-47b7-af2c-e4525cf9b6a5", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents Taysha's traction, solution, and roadmap, generating interest in the company's approach.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "team_bio", "function": "other", "notes": "The slide uses a grid layout to associate individuals with their past or current corporate affiliations via logos.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/12", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "7bbb1ef5-c9d3-47b7-af2c-e4525cf9b6a5", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents Taysha's traction, solution, and roadmap, generating interest in the company's approach.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "other", "function": "establish_context", "notes": "The slide highlights institutional credibility and R&D capabilities through a specific academic partnership.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/13", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "7bbb1ef5-c9d3-47b7-af2c-e4525cf9b6a5", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents Taysha's traction, solution, and roadmap, generating interest in the company's approach.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a hub-and-spoke style diagram to show how two entities contribute to a central set of activities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/14", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "7bbb1ef5-c9d3-47b7-af2c-e4525cf9b6a5", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents Taysha's traction, solution, and roadmap, generating interest in the company's approach.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "section_divider", "function": "transition", "notes": "The background features a faint image of a gel electrophoresis or DNA sequencing result, suggesting a biotech/genomics focus.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/15", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "7bbb1ef5-c9d3-47b7-af2c-e4525cf9b6a5", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents Taysha's traction, solution, and roadmap, generating interest in the company's approach.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a biological pathway diagram and a clinical progression timeline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/16", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-16", "loopMatches": [ { "to": 22, "from": 16, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "c5e05424-6f43-4bdf-8003-ce98529eabe9", "evidence": "The deck presents a logical chain of information, starting with the problem statement, then presenting context and solution.", "position": 0, "objective": "Understand the relationship between residual Hex A activity and the severity of GM2 gangliosidosis", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "context", "function": "establish_context", "notes": "The chart uses a sigmoid-like curve to show the relationship between enzyme activity and disease progression.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/17", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-17", "loopMatches": [ { "to": 22, "from": 16, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "c5e05424-6f43-4bdf-8003-ce98529eabe9", "evidence": "The deck presents a logical chain of information, starting with the problem statement, then presenting context and solution.", "position": 0, "objective": "Understand the relationship between residual Hex A activity and the severity of GM2 gangliosidosis", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "solution", "function": "present_solution", "notes": "The vector uses a P2A self-cleaving linker to ensure 1:1 expression of the two genes under a single promoter.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/18", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-18", "loopMatches": [ { "to": 22, "from": 16, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "c5e05424-6f43-4bdf-8003-ce98529eabe9", "evidence": "The deck presents a logical chain of information, starting with the problem statement, then presenting context and solution.", "position": 0, "objective": "Understand the relationship between residual Hex A activity and the severity of GM2 gangliosidosis", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "The chart uses standard statistical significance markers (*, **, ****) to denote p-values against the control group.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/19", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-19", "loopMatches": [ { "to": 22, "from": 16, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "c5e05424-6f43-4bdf-8003-ce98529eabe9", "evidence": "The deck presents a logical chain of information, starting with the problem statement, then presenting context and solution.", "position": 0, "objective": "Understand the relationship between residual Hex A activity and the severity of GM2 gangliosidosis", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "traction", "function": "show_traction", "notes": "The chart displays longitudinal data for five groups: Heterozygote/Vehicle, three dose levels of TSHA-101 in Knockout mice, and Knockout/Vehicle control.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/20", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-20", "loopMatches": [ { "to": 22, "from": 16, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "c5e05424-6f43-4bdf-8003-ce98529eabe9", "evidence": "The deck presents a logical chain of information, starting with the problem statement, then presenting context and solution.", "position": 0, "objective": "Understand the relationship between residual Hex A activity and the severity of GM2 gangliosidosis", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "The chart displays statistical significance markers (asterisks) comparing treatment groups to the vehicle control.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/21", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-21", "loopMatches": [ { "to": 22, "from": 16, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "c5e05424-6f43-4bdf-8003-ce98529eabe9", "evidence": "The deck presents a logical chain of information, starting with the problem statement, then presenting context and solution.", "position": 0, "objective": "Understand the relationship between residual Hex A activity and the severity of GM2 gangliosidosis", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a table-like structure to define the parameters of a Phase 1/2 clinical trial.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/22", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-22", "loopMatches": [ { "to": 22, "from": 16, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "c5e05424-6f43-4bdf-8003-ce98529eabe9", "evidence": "The deck presents a logical chain of information, starting with the problem statement, then presenting context and solution.", "position": 0, "objective": "Understand the relationship between residual Hex A activity and the severity of GM2 gangliosidosis", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a diagram of the AAV9-hCLN1 gene therapy construct.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/23", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "traction", "function": "show_traction", "notes": "The chart is a standard Kaplan-Meier survival plot used in preclinical efficacy studies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/24", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "traction", "function": "show_traction", "notes": "The chart compares untreated WT, Het, and KO mice against treated mice at 4, 20, and 26 weeks of age.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/25", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "roadmap", "function": "present_solution", "notes": "The slide uses a consistent icon for each pipeline entry.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/26", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "section_divider", "function": "transition", "notes": "The background features a DNA gel electrophoresis image, suggesting a biotech or genetic focus.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/27", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a citation for disease reversibility research.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/28", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-28", "loopMatches": [ { "to": 36, "from": 28, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "b03fcf84-5a66-46c7-b35a-c62163b814de", "evidence": "The deck presents a clear aha moment, highlighting the importance of regulated expression of MECP2.", "position": 1, "objective": "Understand the need for regulated expression of MECP2 in Rett syndrome", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a visual spectrum diagram showing the relationship between MECP2 expression levels and clinical outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/29", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-29", "loopMatches": [ { "to": 36, "from": 28, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "b03fcf84-5a66-46c7-b35a-c62163b814de", "evidence": "The deck presents a clear aha moment, highlighting the importance of regulated expression of MECP2.", "position": 1, "objective": "Understand the need for regulated expression of MECP2 in Rett syndrome", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a diagram to illustrate the genetic construct (scAAV ITR, MeP426, miniMECP2, miRARE).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/30", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-30", "loopMatches": [ { "to": 36, "from": 28, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "b03fcf84-5a66-46c7-b35a-c62163b814de", "evidence": "The deck presents a clear aha moment, highlighting the importance of regulated expression of MECP2.", "position": 1, "objective": "Understand the need for regulated expression of MECP2 in Rett syndrome", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 30, "from": 16, "beatId": "92c49c1c-860e-455e-833b-2b3bc63c64c4", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck presents the problem statements, context, and solution for various neurodegenerative and neurodevelopmental disorders, creating a desire for a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a numbered process flow (1-5) to explain a molecular biology mechanism.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/31", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-31", "loopMatches": [ { "to": 36, "from": 28, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "b03fcf84-5a66-46c7-b35a-c62163b814de", "evidence": "The deck presents a clear aha moment, highlighting the importance of regulated expression of MECP2.", "position": 1, "objective": "Understand the need for regulated expression of MECP2 in Rett syndrome", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "product_demo", "function": "illustrate_case", "notes": "The slide shows immunohistochemistry images (NeuN, myc, DAPI, merge) for two experimental conditions across two mouse IDs each.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/32", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-32", "loopMatches": [ { "to": 36, "from": 28, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "b03fcf84-5a66-46c7-b35a-c62163b814de", "evidence": "The deck presents a clear aha moment, highlighting the importance of regulated expression of MECP2.", "position": 1, "objective": "Understand the need for regulated expression of MECP2 in Rett syndrome", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "product_demo", "function": "illustrate_case", "notes": "The slide displays immunofluorescence staining (NeuN, myc, DAPI, merge) across three brain regions (Thalamus, Hippocampus, Brain Stem) for two treatment groups (PHP.B/mini vs PHP.B/mini-miRARE).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/33", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-33", "loopMatches": [ { "to": 36, "from": 28, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "b03fcf84-5a66-46c7-b35a-c62163b814de", "evidence": "The deck presents a clear aha moment, highlighting the importance of regulated expression of MECP2.", "position": 1, "objective": "Understand the need for regulated expression of MECP2 in Rett syndrome", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart shows survival rates over 35 weeks for various dosage groups of AAV9/MECP2 and TSHA-102.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/34", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-34", "loopMatches": [ { "to": 36, "from": 28, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "b03fcf84-5a66-46c7-b35a-c62163b814de", "evidence": "The deck presents a clear aha moment, highlighting the importance of regulated expression of MECP2.", "position": 1, "objective": "Understand the need for regulated expression of MECP2 in Rett syndrome", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "traction", "function": "show_traction", "notes": "The slide compares TSHA-102 against control and other AAV9 constructs. The bottom box highlights specific adverse event rates (lesions/prolapses).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/35", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-35", "loopMatches": [ { "to": 36, "from": 28, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "b03fcf84-5a66-46c7-b35a-c62163b814de", "evidence": "The deck presents a clear aha moment, highlighting the importance of regulated expression of MECP2.", "position": 1, "objective": "Understand the need for regulated expression of MECP2 in Rett syndrome", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "traction", "function": "show_traction", "notes": "The chart shows survival percentages over time (weeks) for different treatment groups, with diamonds indicating vet-requested euthanasia.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/36", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-36", "loopMatches": [ { "to": 36, "from": 28, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "b03fcf84-5a66-46c7-b35a-c62163b814de", "evidence": "The deck presents a clear aha moment, highlighting the importance of regulated expression of MECP2.", "position": 1, "objective": "Understand the need for regulated expression of MECP2 in Rett syndrome", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "appendix_methodology", "function": "present_framework", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/37", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-37", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a consistent structure for each pipeline asset: program name, target indication, development stage, disease description, and prevalence.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/38", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-38", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "section_divider", "function": "transition", "notes": "The background features a DNA gel electrophoresis image, reinforcing the genetic theme.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/39", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-39", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "product_demo", "function": "present_solution", "notes": "The slide uses a list-based structure to detail the mechanism, clinical impact, and prevalence for each pipeline asset.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/40", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-40", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "other", "function": "establish_context", "notes": "The slide highlights infrastructure capabilities, specifically listing Sartorius equipment and color-coded floor plan areas.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/41", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-41", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "traction", "function": "show_traction", "notes": "The slide includes a footnote clarifying the cash position as of June 30, 2020, adjusted for subsequent financing.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/42", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-42", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a T-shaped graphic as a visual anchor, likely referencing the company's branding or a 'T' for 'Timeline'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/43", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-43", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 44, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/44", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-44", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 45, "slideType": "section_divider", "function": "transition", "notes": "The image is a classic representation of DNA sequencing or fingerprinting, often used in biotech pitch decks to signify core proprietary technology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/45", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-45", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 46, "slideType": "solution", "function": "present_solution", "notes": "The diagram illustrates a molecular biology workflow for AAV capsid engineering.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/46", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-46", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 47, "slideType": "solution", "function": "present_solution", "notes": "The slide highlights the potential to bypass immune responses for gene therapy redosing.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/47", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-47", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 48, "slideType": "traction", "function": "show_traction", "notes": "Includes a disclaimer about intellectual property rights at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/48", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-48", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 49, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a numbered process flow (1-5) to explain a biological mechanism.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/49", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-49", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 50, "slideType": "other", "function": "present_framework", "notes": "The slide outlines a specific R&D process (Reg1 and MiRARE) for gene therapy target identification.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/50", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-50", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 51, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide highlights a specific 'miRARE' target panel derived from the data analysis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/51", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-51", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 52, "slideType": "section_divider", "function": "transition", "notes": "The background features a gel electrophoresis image, common in biotech/genomics pitch decks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/52", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-52", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 53, "slideType": "problem_statement", "function": "frame_problem", "notes": "The chart is a box-and-whisker plot comparing age of onset, death, and last report across multiple genetic conditions, highlighting SURF1.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/53", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-53", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 54, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a molecular diagram of glycogen branching and a therapeutic component breakdown (AAV9 + hGBE1 + Intrathecal delivery).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/54", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-54", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 55, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a bar chart of EPM2A/EPM2B cases by country and a biological process diagram showing the transition from glycogen to Lafora bodies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/55", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-55", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 56, "slideType": "solution", "function": "present_solution", "notes": "Includes a scientific diagram of glycogen branching and a bar chart showing Gys1 deficiency impact.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/56", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-56", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 57, "slideType": "traction", "function": "show_traction", "notes": "The slide uses Kaplan-Meier survival curves and longitudinal body mass measurements to validate the therapeutic hypothesis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/57", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-57", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 58, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a visual representation of MAPT mutations linked to specific FTLD-tau subtypes and a process diagram of tau aggregation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/58", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-58", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 59, "slideType": "section_divider", "function": "transition", "notes": "The background image is a DNA gel electrophoresis, suggesting a biotech or genetic research context.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/59", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-59", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 60, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a visual mechanism of action diagram showing the silencing of Ube3a-ATS to restore Ube3a expression.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/60", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-60", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 61, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a visual representation of the genetic mechanism (Typical vs Premutation vs Full mutation).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/61", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-61", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 62, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a bar chart of clinical features and a schematic of the AAV9-shRNA mechanism.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/62", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-62", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 63, "slideType": "section_divider", "function": "transition", "notes": "The background features a DNA gel electrophoresis image, reinforcing the genetic focus.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/63", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-63", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 64, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a biological diagram of the synapse and a therapeutic approach summary (AAV9 + hSLC6A1 + Intrathecal delivery).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/64", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-64", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 65, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a visual equation for the therapeutic approach (AAV9 + hSLC13A5 + Intrathecal delivery).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/65", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-65", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-5095-745c-b54c-b78e5ae1b904", "docSlug": "0dc8a543e5d2136d106b59f85712c2a9", "documentTitle": "Taysha | IPO Presentation Deck | 66 slides", "authorId": "taysha", "authorName": "Taysha Gene Therapies", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 66, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a diagram of the KCNQ2 protein structure and a visual representation of a gene therapy approach (AAV9 + hKCNQ2 + Intrathecal delivery).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-5095-745c-b54c-b78e5ae1b904/66", "deckHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904", "deckAnchorHref": "/decks/019de070-5095-745c-b54c-b78e5ae1b904#slide-66", "loopMatches": [], "arcBeatMatches": [ { "to": 66, "from": 31, "beatId": "a2d2f153-e121-48a0-8c8f-2d7d544ceb56", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, presenting the company's plans for clinical and commercial development.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de070-513c-77de-8f7a-7ee35ff709d4", "docSlug": "c6407fb957699e2516f3093b3b35ab17", "documentTitle": "Teladoc | Mergers and Acquisitions Presentation Deck | 36 slides", "authorId": "teladoc", "authorName": "Teladoc Health", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2020-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/QjWPd7YpCXNZHYutORT3T2RU8fwlMk9xOWyw3dKqzkQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jNjQwN2ZiOTU3Njk5ZTI1MTZmMzA5M2IzYjM1YWIxNy9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de070-513c-77de-8f7a-7ee35ff709d4/1", "deckHref": "/decks/019de070-513c-77de-8f7a-7ee35ff709d4", "deckAnchorHref": "/decks/019de070-513c-77de-8f7a-7ee35ff709d4#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "25e6278e-d025-4e35-bdd9-2f3d0e7065fa", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "Slides 1-4 provide an overview of Teladoc Health's strategic vision and industry-leading assets", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/Qw19RJLQVyCCc2yxY6xMOvCOREkAg2KTyUBYL5Br524/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jNjQwN2ZiOTU3Njk5ZTI1MTZmMzA5M2IzYjM1YWIxNy9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/9i4-a4F1ud89PB7IlO-CiHAdftNcK8EjKVhs5TWe6Zo/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jNjQwN2ZiOTU3Njk5ZTI1MTZmMzA5M2IzYjM1YWIxNy9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/0_v7lwvhbosnGIvwnLpMmxB031dOL3LSr8a1Qq3h_qI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jNjQwN2ZiOTU3Njk5ZTI1MTZmMzA5M2IzYjM1YWIxNy9wMDAxLnBuZw" } ] }